Because of rising awareness of this disease in recent years, the disease-specific survival rates were 81%, 83%, and 91% in 1989–2008, 2009–2013, and 2014–2017, respectively, showing an increasing trend ( 19 ).
← all excerpts
Case Report: A novel germline donor splicing site mutation of <i>RB1</i> gene in a Chinese Tibetan pedigree with familial retinoblastoma.
1
—
—